Has Serge Tobias received payments from drug or device companies?

Yes. Drug and device makers reported $32,821 in general payments to Serge Tobias across 388 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Serge Tobias did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Serge Tobias come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Serge Tobias

Clinical Cardiac Electrophysiology · Long Beach, CANPI 1679500193

Payments from drug & device makers

$32,821in general payments, 2019–2025

Across 388 payments — averaging $84.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$25K
Johnson & Johnson$1K
Amgen$624
Novartis$623
Pfizer$554
Abbott$535
plus $4K from 35 others

What the payments were for

Consulting fees$1500%
Speaking & faculty fees$21,45065%
Travel & lodging$2,3357%
Food & beverage$8,70127%
Education$1851%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	38	$25,255
Johnson & Johnson	66	$1,163
Amgen	28	$624
Novartis	35	$623
Pfizer	31	$554
Abbott	8	$535
Sanofi-aventis U.S. LLC	21	$447
AstraZeneca	21	$373
E.r. Squibb & Sons, L.L.C.	30	$370
Boehringer Ingelheim	11	$311
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	13	$262
Merck	13	$248
Angiodynamics, Inc.	1	$248
Esperion Therapeutics, Inc.	10	$217
Philips North America LLC	2	$168
Astellas Pharma US Inc	2	$155
Actelion Pharmaceuticals US, Inc.	6	$119
Kiniksa Pharmaceuticals, Ltd.	5	$112
Cvrx, Inc.	5	$103
Regeneron Healthcare Solutions, Inc.	5	$99
Heartflow, Inc.	4	$98
Cardiva Medical, Inc.	4	$88
W. L. Gore & Associates, Inc.	4	$84
Atricure, Inc.	1	$66
Kestra Medical Technology Services, Inc.	2	$44
Gilead	2	$41
Biotronik Inc.	1	$40
Bayer	2	$39
Corindus Inc.	1	$36
Novo Nordisk	2	$36
Boston Scientific	2	$34
Biosense Webster, Inc.	1	$34
Impulse Dynamics (USA) Inc.	2	$31
Bardy Diagnostics, Inc.	2	$26
Alnylam Pharmaceuticals Inc.	1	$24
Biom'up France SAS	1	$22
Amarin Pharma, Inc.	1	$22
Smith+Nephew	1	$19
Abiomed	1	$19
Kowa Pharmaceuticals America, Inc.	1	$18
Arbor Pharmaceuticals, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,821 in reported general payments places this provider in the 45th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California →

Other clinical cardiac electrophysiology in Long Beach

Mark LeeLong Beach$173K
David KrummenSan Diego$7.3M
Jonathan DukesVentura$2.9M
Shephal DoshiSanta Monica$2.9M
Arash AryanaSacramento$2.4M
Marco PerezStanford$2.1M
Rahul DoshiLos Angeles$2M
Mayer RashtianPasadena$1.8M
Rajesh BankerNewport Beach$1.6M
Edward GerstenfeldSan Francisco$1.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →